These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4829160)

  • 21. Use of cyproterone acetate (CPA) in the treatment of acne, hirsutism and virilism.
    Hammerstein J; Meckies J; Leo-Rossberg I; Moltz L; Zielske F
    J Steroid Biochem; 1975 Jun; 6(6):827-36. PubMed ID: 126335
    [No Abstract]   [Full Text] [Related]  

  • 22. [The response to gonadotropin-releasing hormone in hirsutism after treatment with cyproterone acetate].
    Kocijancic A; Pfeifer M; Prezelj J; Meden-Vrtovec H; Vrhovec I
    Jugosl Ginekol Opstet; 1982; 22(1-2):16-9. PubMed ID: 6215543
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Long-term treatment of virilized women with cyproterone acetate (author's transl)].
    Abrahamsson L; Hackl H; Lindström B; Sogn J
    Wien Klin Wochenschr; 1981 Sep; 93(17):552-6. PubMed ID: 6458162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Treatment of hirsutism with combined pill containing drospirenone.
    Gregoriou O; Papadias K; Konidaris S; Bakalianou K; Salakos N; Vrachnis N; Creatsas G
    Gynecol Endocrinol; 2008 Apr; 24(4):220-3. PubMed ID: 18382909
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modifications of hormone excretion patterns after treatment with 6alpha-methyl-17alpha-acetoxyprogesterone and 17alpha-ethynyl-estradiol.
    Baldratti G; Casteguaro E
    Arzneimittelforschung; 1967 Oct; 17(10):1301-4. PubMed ID: 5632882
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical use of antiandrogens in the female].
    Moltz L; Schwartz U; Hammerstein J
    Gynakologe; 1980 Mar; 13(1):1-17. PubMed ID: 6299908
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activation of PRL secretion by combined treatment with cyproterone acetate and ethinylestradiol.
    Valenti G; Vescovi PP; Gerra G; Rastelli G; Butturini U
    J Endocrinol Invest; 1985 Jun; 8(3):269-72. PubMed ID: 3161934
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hormonal treatment of hirsutism].
    Floersheim Y; Keller PJ
    Schweiz Med Wochenschr; 1976 Apr; 106(17):573-4. PubMed ID: 982010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The management of female hirsutism with the anti-androgen agent cyproterone.
    Kwok PC; Correy JF; Senator GB
    Asia Oceania J Obstet Gynaecol; 1985 Jun; 11(2):233-40. PubMed ID: 4038178
    [No Abstract]   [Full Text] [Related]  

  • 30. Gonadotropin-releasing hormone agonist (GnRH-A) in hirsutism.
    Falsetti L; Pasinetti E; Ceruti D
    Acta Eur Fertil; 1994; 25(5):303-6. PubMed ID: 7660719
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of estrogen administration on androgen production and plasma luteinizing hormone in hirsute women.
    Kirschner MA; Bardin CW; Hembree WC; Ross GT
    J Clin Endocrinol Metab; 1970 Jun; 30(6):727-32. PubMed ID: 5444560
    [No Abstract]   [Full Text] [Related]  

  • 32. [A new ovulation inhibitor antiandrogen].
    Millet-part A; Blanes-espi A; Ferrer-barriendos J; Siqueira L; Acosta E
    J Bras Ginecol; 1984 Mar; 94(3):91-7. PubMed ID: 12266391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Disappearance of amenorrhea after thymectomy. A case report.
    Lundberg PO; Persson BH
    Acta Soc Med Ups; 1969; 74(3-4):206-8. PubMed ID: 5212570
    [No Abstract]   [Full Text] [Related]  

  • 34. The effect of some progestins on pituitary gonadotrophin excretion patterns in women.
    Keller PJ
    Bull Schweiz Akad Med Wiss; 1970 Oct; 25(4-6):379-85. PubMed ID: 5510166
    [No Abstract]   [Full Text] [Related]  

  • 35. Comparison of the clinical efficacy of flutamide and spironolactone plus ethinyloestradiol/cyproterone acetate in the treatment of hirsutism: a randomised controlled study.
    Karakurt F; Sahin I; Güler S; Demirbas B; Culha C; Serter R; Aral Y; Bavbek N
    Adv Ther; 2008 Apr; 25(4):321-8. PubMed ID: 18389188
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Luboshitzky R; Herer P; Shen-Orr Z
    Exp Clin Endocrinol Diabetes; 2004 Feb; 112(2):102-7. PubMed ID: 15031776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutism.
    Batukan C; Muderris II
    Fertil Steril; 2006 Feb; 85(2):436-40. PubMed ID: 16595223
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Pharmacologic inhibition of the libido: therapy or repression? I. Pharmacologic aspects. Effect of sex hormones and in particular testosterone on male behavior. Effect of cyproterone acetate].
    Legros JJ
    Acta Psychiatr Belg; 1982; 82(5):505-19. PubMed ID: 6221507
    [No Abstract]   [Full Text] [Related]  

  • 39. Endocrine function in male and female homosexuals.
    Ismail AA; Adamopoulos DA; Loraine JA; Dove GA
    J Endocrinol; 1970 Dec; 48(4):xxxvi+. PubMed ID: 5489056
    [No Abstract]   [Full Text] [Related]  

  • 40. Cyproterone acetate treatment of females with hyperandrogenism.
    Julesz J; Faredin I; Tóth I; László FA
    Endokrinologie; 1981 Dec; 78(2-3):168-74. PubMed ID: 6460612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.